ArticleDiscover oncology2024

BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancer.

Zhi-Ming Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.